Study for effect of classic prescription Danggui Shaoyao Powder in the treatment of Wet-stasis syndrome Non-alcoholic Fatty Liver Disease

Not Applicable

Not yet recruiting

• Conditions: onalcoholic fatty liver disease

• Registration Number: ITMCTR2000002925
• Lead Sponsor: Shuguang Hospital affiliated to Shanghai University of TCM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-02-20

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Meet the diagnostic standard of the nonalcoholic fatty liver disease;
2. Meet the standard of Wet-stasis syndrome;
3. Aged 18-65 years old;
4. ALT is greater than the upper limit of normal (male> 50IU / L, female> 40 IU / L), and less than or equal to 5 times the upper limit of normal;
5. Signed informed consent.

Exclusion Criteria

1. Those who have used other liver-protecting and enzyme-lowering drugs which might affect the efficacy evaluation in the past 3 months;
2. Patients with alcoholic fatty liver (male alcohol intake> 20g / d, female alcohol intake> 10g / d);Patients with cirrhosis, HBV, HCV and other liver diseases; Patients with autoimmune liver disease; People who are taking any drug which might cause fatty liver;
3. Those with normal liver function;
4. Those who have undergone gastrointestinal weight loss surgery in the past year or those who have lost weight by more than 10% after taking weight-loss drugs within the past 3 months;
5. Pregnant women, lactating women, patients with primary diseases such as cardiovascular, lung, kidney, hematopoietic system, and other major diseases such as malignant tumors.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified